Kewaunee Scientific
(NASDAQ) KEQU
Kewaunee Scientific Financials at a Glance
Market Cap
$100.70M
Revenue (TTM)
$282.00M
Net Income (TTM)
$9.62M
EPS (TTM)
$3.22
P/E Ratio
10.90
Dividend
$0.00
Beta (Volatility)
0.47 (Low)
Dividend
$0.00
Beta (Volatility)
0.47 (Low)
Price
$36.58
Volume
49
Open
$35.13
Price
$36.58
Volume
49
Open
$35.13
Previous Close
$36.58
Daily Range
$35.13 - $36.58
52-Week Range
$33.27 - $60.89
Estimated Earnings Date
Jul 1, 2026
Dividend
$0.00
Beta (Volatility)
0.47 (Low)
Price
$36.58
Volume
49
Open
$35.13
Previous Close
$36.58
Daily Range
$35.13 - $36.58
52-Week Range
$33.27 - $60.89
Estimated Earnings Date
Jul 1, 2026
KEQU News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kewaunee Scientific
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
1,239
CEO
Thomas D. Hull, III, MBA
Website
www.kewaunee.comHeadquarters
Statesville, NC 28677-2927, US
KEQU Financials
Key Financial Metrics (TTM)
Gross Margin
28.52%
Operating Margin
5.93%
Net Income Margin
3.41%
Return on Equity
13.63%
Return on Capital
12.71%
Return on Assets
5.39%
Earnings Yield
9.17%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$100.70M
Shares Outstanding
2.87M
Volume
49
Avg. Volume
3.70K
Financials (TTM)
Gross Profit
$80.44M
Operating Income
$16.72M
EBITDA
$21.47M
Operating Cash Flow
$0.00
Capital Expenditure
$0.00
Free Cash Flow
$0.00
Cash & ST Invst.
$11.62M
Total Debt
$56.82M
Kewaunee Scientific Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$71.40M
-7.5%
Gross Profit
$21.25M
-11.6%
Gross Margin
29.75%
N/A
Market Cap
$100.70M
N/A
Market Cap/Employee
$100.10K
N/A
Employees
1,006
N/A
Net Income
$3.39M
-30.1%
EBITDA
$4.67M
-52.7%
Quarterly Fundamentals
Total Cash
$11.62M
-22.3%
Total Debt
$56.82M
+13.3%
Accounts Receivable
$58.74M
-5.8%
Inventory
$30.53M
-7.1%
Long Term Debt
$47.14M
+9.9%
Short Term Debt
$9.68M
+33.3%
Return on Assets
5.39%
N/A
Return on Invested Capital
12.86%
N/A
Free Cash Flow
-$10.16M
-214.3%
Operating Cash Flow
-$13.17M
-240.0%